• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[利福平治疗肺结核和非特异性炎症性肺部疾病的研究]

[Study of rifampicin in the treatment of tuberculosis and nonspecific inflammatory lung diseases].

作者信息

Rudoĭ N M, Zankisova I G, Eĭsaev B A

出版信息

Antibiotiki. 1975 Oct;20(10):945-8.

PMID:813565
Abstract

Benemecin, a Polish rifampicin was tested in vitro and clinically for the treatment of 2 groups of patients, i.e. 28 patients with chronic destructive tuberculosis of the lungs and 30 patients with non-specific pneumonia. High tuberculostatic activity of the drug in vitro was found. The clinical trials showed high efficiency of benemecin in the treatment of chronic destructive tuberculosis of the lungs and pneumonia of non-specific etiology. The drug was mainly well tolerated by the patients.

摘要

贝内霉素是一种波兰产的利福平,对两组患者进行了体外试验和临床试验,即28例慢性肺破坏性结核患者和30例非特异性肺炎患者。发现该药物在体外具有很高的抗结核活性。临床试验表明,贝内霉素治疗慢性肺破坏性结核和非特异性病因的肺炎疗效显著。患者对该药物的耐受性总体良好。

相似文献

1
[Study of rifampicin in the treatment of tuberculosis and nonspecific inflammatory lung diseases].[利福平治疗肺结核和非特异性炎症性肺部疾病的研究]
Antibiotiki. 1975 Oct;20(10):945-8.
2
[Rifampicin and ethanbutol in daily and intermittent treatment of chronic advanced cavernous pulmonary tuberculosis resistant to many drugs. Preliminary communication. Early results].
Gruzlica. 1973 Nov;41(11):1129-37.
3
[Results of the use of rifampicin and ethambutol in complex treatment of chronic destructive pulmonary tuberculosis].[利福平与乙胺丁醇在慢性破坏性肺结核综合治疗中的应用结果]
Probl Tuberk. 1976;3:27-31.
4
[Effectiveness of treatment of patients with destructive forms of pulmonary tuberculosis with rifampicin and ethambutol].[利福平与乙胺丁醇治疗肺结核毁损型患者的疗效]
Klin Med (Mosk). 1974 Dec;52(12):31-4.
5
[Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].利福平与乙胺丁醇治疗慢性毁损性肺结核
Probl Tuberk. 1980 Jun(6):30-3.
6
[Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1982 Oct-Dec;31(4):315-20.
7
Short-course treatment regimens for patients with tuberculosis.结核病患者的短程治疗方案。
Arch Intern Med. 1980 Jun;140(6):827-9.
8
[Bacteriostatic activity of the blood in pulmonary tuberculosis and its clinical significance].[肺结核患者血液的抑菌活性及其临床意义]
Probl Tuberk. 1979 Jan(1):33-7.
9
[Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].[利福平与乙胺丁醇治疗多耐药杆菌超慢性肺结核的长期结果]
Ftiziologia. 1973 Sep-Oct;22(5):477-84.
10
[Causes of failure in neutralization, recovery and social rehabilitation of chronic eliminators of Koch bacilli treated with rifampin and ethambutol].[利福平与乙胺丁醇治疗的慢性结核杆菌清除者中和、康复及社会康复失败的原因]
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1978 Jul-Sep;27(3):153-9.